Because of the direct action of ERK3/MK5 complex on the FOXO1-mediated transcriptional signaling, we decided to test the impact of ERK3 on the development of obesity and diabetes in vivo. The gene discussed is MAPK6; the disease is obesity due to melanocortin 4 receptor deficiency.